U.S. market Closed. Opens in 3 hours 4 minutes

DNMR | Danimer Scientific, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue46.68M53.22M58.75M47.33M32.34M
Cost of Revenue82.64M63.63M57.87M35.88M21.24M
Gross Profit-35.95M-10.41M884.00K11.46M11.11M
Operating Expenses89.23M113.53M100.27M27.19M21.51M
Selling, General & Admin67.79M81.59M80.00M19.34M16.03M
Research & Development21.44M31.94M20.27M7.85M5.48M
Other Operating Expenses1.00K723.00K-44.00K-31.00K277.00K
Operating Income-125.19M-187.43M-99.39M-15.74M-10.40M
Other Expenses / Income-29.97M6.87M26.05M3.16M-5.03M
Before Tax Income-155.15M-180.57M-73.34M-12.57M-15.43M
Income Tax Expenses319.00K-810.00K-13.23M2.40M4.08M
Net Income-155.47M-179.76M-60.11M-14.97M-19.51M
Interest ExpensesN/A112.25M763.00K2.43M3.48M
Basic Shares Outstanding102.00M101.10M93.08M84.54M25.37M
Diluted Shares Outstanding102.00M101.10M93.08M84.54M25.37M
EBITDA-96.13M-48.23M-88.80M-10.30M-4.16M
EBITDA Margin-205.91%-90.63%-151.15%-21.76%-12.87%
EBIT-155.15M-68.32M-72.58M-10.15M-11.95M
EBIT Margin-332.35%-128.37%-123.54%-21.44%-36.96%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙